Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records)
|Query Trace: Tuberculosis and meta-analysis and NAT2[original query]|
| Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008 Sep 12 (9): 994-1002.
Sun F, Chen Y, Xiang Y, Zhan
| NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012 May 16 (5): 589-95.
Wang P-Y, Xie S-Y, Hao Q, Zhang C, Jiang B
| The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2014 Jun 24 34-40.
Sheng Yun-Jian, Wu Gang, He Hong-Yan, Chen Wen, Zou Yong-Sheng, Li Qin, Zhong Li, Huang Yong-Mao, Deng Cun-Lia
| The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.
British journal of clinical pharmacology 2018 Jul .
Zhang Min, Wang Shuqiang, Wilffert Bob, Tong Rongsheng, van Soolingen Dick, van den Hof Susan, Alffenaar Jan-Will
| NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
Pharmacogenetics and genomics 2018 Jul 28 (7): 167-176.
Suvichapanich Supharat, Fukunaga Koya, Zahroh Hilyatuz, Mushiroda Taisei, Mahasirimongkol Surakameth, Toyo-Oka Licht, Chaikledkaew Usa, Jittikoon Jiraphun, Yuliwulandari Rika, Yanai Hideki, Wattanapokayakit Sukanya, Tokunaga Katsus
| Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence.
Bioscience reports 2018 12 39 (1): .
Khan Saif, Mandal Raju K, Elasbali Abdulbaset Mohamed, Dar Sajad A, Jawed Arshad, Wahid Mohd, Mahto Harishankar, Lohani Mohtashim, Mishra Bhartendu Nath, Akhter Naseem, Rabaan Ali A, Haque Shafi
| Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
BMJ open 2019 Aug 9 (8): e027940.
Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik
| NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2019 3 23 (3): 293-305.
Richardson M, Kirkham J, Dwan K, Sloan D J, Davies G, Jorgensen A
| A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis.
Clinical therapeutics 2020 Oct .
Hong Boi-Lam, D'Cunha Ronilda, Li Peizhi, Al-Shaer Mohammad H, Alghamdi Wael A, An Guohua, Peloquin Charl
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: